Value of multi-detector computed tomography combined with serum tumor markers in diagnosis, preoperative, and prognostic evaluation of pancreatic cancer

Table 3 Correlation analysis of CA199, CA242, CEA expression levels, and clinicopathological factors in PC group

	n	CA199 (U/mL)	CA242 (U/mL)	CEA(ng/mL)
Gender
Male	56	328.24 ± 88.23	265.87 ± 78.23	168.71 ± 43.20
Female	29	320.59 ± 79.63	276.27 ± 80.02	158.83 ± 37.69
Age (years)
< 60	37	318.88 ± 80.66	263.25 ± 68.24	163.22 ± 47.12
≥ 60	48	330.25 ± 92.24	274.17 ± 85.21	166.97 ± 49.20
Tumor site
Head of pancreas	55	330.29 ± 89.36	273.54 ± 79.32	167.23 ± 45.23
Cauda pancreatitis	30	323.83 ± 79.25	261.89 ± 75.62	161.88 ± 50.72
Clinical stage
I + II	53	165.98 ± 41.23	136.22 ± 36.78	96.41 ± 23.67
III + IV	32	590.05 ± 132.54^a	470.03 ± 126.34^a	279.50 ± 67.82^a
Differentiation degree
High and middle differentiation	34	156.84 ± 39.66	149.83 ± 41.85	112.06 ± 36.78
Low differentiation	51	428.16 ± 116.24^a	448.80 ± 113.65^a	218.08 ± 64.27^a
Distant metastasis
No	75	262.84 ± 62.30	217.37 ± 60.31	124.28 ± 32.64
Yes	10	796.55 ± 196.33^a	659.74 ± 156.79^a	423.52 ± 102.39^a

ISSN: 1477-7819